PyInvesting

Market research

RME.F ResMed Inc

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
28B
P/E ratio
22.01
Analyst target
261.67
Dividend yield
1.2%
Beta
0.75

Community

Investor discussion

1 comment

Investor-9DA92591

5 years, 4 months ago

ResMed Inc is currently in a long term uptrend where the price is trading 23.1% above its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.1.

ResMed Inc's total revenue rose by 8.7% to $800M since the same quarter in the previous year.

Its net income has increased by 11.8% to $180M since the same quarter in the previous year.

Finally, its free cash flow grew by 221.1% to $135M since the same quarter in the previous year.

Based on the above factors, ResMed Inc gets an overall score of 5/5.